510(k) Report

510(k) · Cleared

Cleared

InterCollagen® Guide

K223912510(k) TraditionalCleared Aug 17, 2023231-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sigmagraft, Inc. · NPL Barrier, Animal Source, Intraoral

Cleared on Aug 17, 2023 as substantially equivalent to K173562 (Institut Straumann AG, 2018) after a 231-day review. Its family tree reaches back 7 generations to 1995.

Decided
Aug 17, 2023
Review
231 days
Class
Class II
Product code
NPL
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K924408 (1995). 10 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 7 generations backK924408 Colla-Tec Absorbable Collagen MembraneColla-Tec, Inc. · 1995 · Recalled
  2. 6 generations backK992216 Biomend Extend Absorbable Collagen Membrane, Biomend Absorbable…Integra Lifesciences Corp. · 1999 · Recalled
  3. 5 generations backK042197 Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and Bone…Ed. Geistlich Soehne AG Fuer Chemische Industrie · 2004
  4. 4 generations backK050446 Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and BoneEd. Geistlich Soehne AG Fuer Chemische Industrie · 2005
  5. 3 generations backK101453 Vitala Natural Resorbable Collagen MembraneObi Biologics, Inc. · 2011
  6. 2 generations backK141177 Vitala Porcine Derived Collagen MembraneOsteogenics Biomedical, Inc. (Formerly Obi Biologi · 2015
  7. 1 generation backK173562 Straumann Jason MembraneInstitut Straumann AG · 2018
  8. This deviceK223912 InterCollagen® GuideSigmagraft, Inc. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K924408Colla-Tec Absorbable Collagen MembraneColla-Tec, Inc.19952
−6K992216Biomend Extend Absorbable Collagen Membrane, Biomend Absorbable Collagen…Integra Lifesciences Corp.19991
−5K042197Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and Bone RegenerationEd. Geistlich Soehne AG Fuer Chemische Industrie2004—
−4K050446Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and BoneEd. Geistlich Soehne AG Fuer Chemische Industrie2005—
−3K101453Vitala Natural Resorbable Collagen MembraneObi Biologics, Inc.2011—
−2K141177Vitala Porcine Derived Collagen MembraneOsteogenics Biomedical, Inc. (Formerly Obi Biologi2015—
−1K173562Straumann Jason MembraneInstitut Straumann AG2018—
0 (this device)K223912InterCollagen® GuideSigmagraft, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200610
200810
FIG. 1 — Lineage of K223912, 1995–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NPL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NPL device

  1. #1 K212463 Geistlich Bio-Gide, Geistlich Bio-Gide Shape…score 14.5 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K173562Straumann Jason Membrane
Summary page 4
…L Classification Panel: Dental Predicate Device Primary Predicate: Straumann Jason Membrane (K173562) Common Name: Bone Grafting Material Classification Name:…
Institut Straumann AG2018—

Also cleared against K173562: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 7 companies; a new generation was cleared every 4.2 years on median.
  • 2 of the 10 ancestors have a recall of any class.
  • 1 other device also cites its predicate K173562.

How does its category compare?

All NPL devices

NPL Barrier, Animal Source, Intraoral: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · NPL

5in 2025

2007: 12008: 42009: 32010: 22011: 42013: 22014: 52015: 12016: 32017: 32018: 12019: 12020: 22021: 22022: 32023: 22024: 32025: 5
2007high 5 (2014) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NPL

132in 2025

2008: 172 days median2009: 193 days median2011: 286 days median2014: 140 days median2016: 184 days median2017: 200 days median2022: 290 days median2024: 263 days median2025: 132 days median
2007high 290 (2022) · low 132 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NPL

6in 2019

2012: 32019: 6
2007high 6 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NPL

39in 2025

2012: 32013: 22014: 32015: 52016: 92017: 182018: 142019: 222020: 82021: 112022: 192023: 52024: 202025: 39
2007high 39 (2025) · low 0 (2007)2025

MAUDE reports naming product code NPL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
2008417200
2009319300
20102—00
2011428600
20120—33
20132—02
2014514003
20151—05
2016318409
20173200018
20181—014
20191—622
20202—08
20212—011
20223290019
20232—05
20243263020
20255132039
20260—0—

What is it indicated for?

InterCollagen® Guide alone or in combination with suitable augmentation materials (like autogenous bone, allogeneic, xenogeneic or alloplastic bone replacement materials) is indicated for immediate or delayed guided tissue and bone regeneration.

• in the context of a treatment of fenestration defects

• in case of dehiscence defects

• after apicoectomy and resection of retained teeth

• in extraction sockets after tooth extractions

• in case of immediate or delayed augmentation around implants in extraction sockets

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223912: InterCollagen® Guide.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K223912

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026